Clinical value of whole-body positron em
โ
G. Beets; Professor F. Penninckx; C. Schiepers; L. Filez; L. Mortelmans; R. Kerr
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 587 KB
## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr